Crystalline derivative of 2- (5-chlorothien-2-yl)-n-...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/14 (2006.01) A61K 31/5377 (2006.01)

Patent

CA 2508699

(E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2- oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide in substantially crystalline form, pharmaceutical formulations thereof, processes for preparing it, and its use inmedicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.

L'invention concerne des (E)-2-(5-chlorothiène-2-yle)-N-{(3S)-1[(1S)-1-méthyle-2-morpholine-4-yle-2-oxoéthyle]-2-oxopyrrolidine-3-yle}éthène-sulfonamides sous forme sensiblement cristalline, des formulations pharmaceutiques desdits composés, des procédés de préparation correspondants et leur utilisation dans le domaine médical, notamment pour améliorer un état clinique pour lequel un inhibiteur du facteur Xa est indiqué.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Crystalline derivative of 2- (5-chlorothien-2-yl)-n-... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline derivative of 2- (5-chlorothien-2-yl)-n-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline derivative of 2- (5-chlorothien-2-yl)-n-... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1433049

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.